Nvidia Invests $50 Million in Recursion to Train AI Models for Drug Discovery

StreetInsider2023-07-12

Nvidia invested $50 million to speed up training of biotech firm Recursion's artificial intelligence models for drug discovery, which the chip designer can then potentially license out, the companies ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Mohamed elsage
2023-07-13
Mohamed elsage
Mohamed elsage
- Mohamed elsage:
  100000000000000
- Mohamed elsage:
  5000000000000
- Mohamed elsage:
  5000000000
Kennoobie
2023-07-13
Kennoobie
Boom ... shooting up crazily
- Mohamed elsage:
  1000000000

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2350044430?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-07-12 20:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2350044430","market":"us","top_or_hot":-1,"title":"Nvidia Invests $50 Million in Recursion to Train AI Models for Drug Discovery","media":"StreetInsider","content":"<div>\n<p>Nvidia invested $50 million to speed up training of biotech firm Recursion's artificial intelligence models for drug discovery, which the chip designer can then potentially license out, the companies ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=21899966\">Source Link</a>\n\n</div>\n","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia Invests $50 Million in Recursion to Train AI Models for Drug Discovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia Invests $50 Million in Recursion to Train AI Models for Drug Discovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-07-12 20:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=21899966><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nvidia invested $50 million to speed up training of biotech firm Recursion's artificial intelligence models for drug discovery, which the chip designer can then potentially license out, the companies ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=21899966\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVDA","symbol_name":"英伟达","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=21899966","article_id":"2350044430","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2350044430","pubTimestamp":1689165924,"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"Nvidia invested $50 million to speed up training of biotech firm Recursion's artificial intelligence models for drug discovery, which the chip designer can then potentially license out, the companies ","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVDA":"英伟达","RXRX":"Recursion Pharmaceuticals, Inc."},"translate_title":"英伟达投资5000万美元进行递归训练人工智能药物发现模型","themeId":"95e3e7595ac2407d82a2e646db9ba6e0","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RXRX":1.1,"NVDA":1},"content_text":"Nvidia invested $50 million to speed up training of biotech firm Recursion's artificial intelligence models for drug discovery, which the chip designer can then potentially license out, the companies said on Wednesday.Recursion will train AI models on Nvidia's cloud platform using its own biological and chemical datasets exceeding 23,000 terabytes.Nvidia could then license the AI models to biotech firms via BioNeMo, a generative AI cloud service for drug discovery that it rolled out widely earlier this year.The companies did not specify whether Nvidia will take a stake in Recursion. The drug developer did not immediately respond to a Reuters request for clarification.Recursion, which has partnered with drugmakers such as Bayer and Roche, plans to use Nvidia's software to support its own pipeline as well as current and future partners.The biopharma company, which went public in 2021, runs the Recursion OS platform that gives drugmakers access to datasets required for designing and developing therapeutics.Recursion is conducting human trials for five of its drugs, including a candidate that is in mid-stage trials to treat a type of neurovascular disease caused by malformation of small blood vessels in the brain. The company uses AI to discover drugs.Recursion's other backers include Abu Dhabi sovereign investor Mubadala and UK-based investment firm Baillie Gifford & Co.In May, Recursion, whose advisers include AI pioneer Yoshua Bengio, had agreed to buy two companies in the AI-driven drug discovery space for $87.5 million. Recursion Pharmaceuticals, Inc. surged over 107% while NVIDIA Corp gained nearly 2% in premarket trading.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[{"id":197325953466504,"gmtCreate":1689215438152,"gmtModify":1689216695332,"author":{"id":"4149410557710562","authorId":"4149410557710562","name":"Mohamed elsage","avatar":"https://community-static.tradeup.com/news/a43cd2065e9d566c3da3119bc912aa93","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Mohamed elsage","listText":"Mohamed elsage","text":"Mohamed elsage","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/197325953466504","repostId":2350044430,"repostType":4,"repost":{"id":"2350044430","pubTimestamp":1689165924,"share":"https://www.laohu8.com/m/news/2350044430?lang=&edition=full","pubTime":"2023-07-12 20:45","market":"us","language":"en","title":"Nvidia Invests $50 Million in Recursion to Train AI Models for Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2350044430","media":"StreetInsider","summary":"Nvidia invested $50 million to speed up training of biotech firm Recursion's artificial intelligence models for drug discovery, which the chip designer can then potentially license out, the companies ","content":"<html><head></head><body><p>Nvidia invested $50 million to speed up training of biotech firm Recursion&#39;s artificial intelligence models for drug discovery, which the chip designer can then potentially license out, the companies said on Wednesday.</p><p>Recursion will train AI models on Nvidia&#39;s cloud platform using its own biological and chemical datasets exceeding 23,000 terabytes.</p><p>Nvidia could then license the AI models to biotech firms via BioNeMo, a generative AI cloud service for drug discovery that it rolled out widely earlier this year.</p><p>The companies did not specify whether Nvidia will take a stake in Recursion. The drug developer did not immediately respond to a Reuters request for clarification.</p><p>Recursion, which has partnered with drugmakers such as Bayer and Roche, plans to use Nvidia&#39;s software to support its own pipeline as well as current and future partners.</p><p>The biopharma company, which went public in 2021, runs the Recursion OS platform that gives drugmakers access to datasets required for designing and developing therapeutics.</p><p>Recursion is conducting human trials for five of its drugs, including a candidate that is in mid-stage trials to treat a type of neurovascular disease caused by malformation of small blood vessels in the brain. The company uses AI to discover drugs.</p><p>Recursion&#39;s other backers include Abu Dhabi sovereign investor Mubadala and UK-based investment firm Baillie Gifford &amp; Co.</p><p>In May, Recursion, whose advisers include AI pioneer Yoshua Bengio, had agreed to buy two companies in the AI-driven drug discovery space for $87.5 million.</p><p> <a href=\"https://laohu8.com/S/RXRX\">Recursion Pharmaceuticals, Inc.</a> surged over 107% while <a href=\"https://laohu8.com/S/NVDA\">NVIDIA Corp</a> gained nearly 2% in premarket trading.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/86828bcf2f80c8d15e786f667dc72d28\" tg-width=\"931\" tg-height=\"609\"/></p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fbe5b0f4a1dba452b226b951acd0af45\" tg-width=\"928\" tg-height=\"608\"/></p><p></p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia Invests $50 Million in Recursion to Train AI Models for Drug Discovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia Invests $50 Million in Recursion to Train AI Models for Drug Discovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-07-12 20:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=21899966><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nvidia invested $50 million to speed up training of biotech firm Recursion's artificial intelligence models for drug discovery, which the chip designer can then potentially license out, the companies ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=21899966\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","RXRX":"Recursion Pharmaceuticals, Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=21899966","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2350044430","content_text":"Nvidia invested $50 million to speed up training of biotech firm Recursion's artificial intelligence models for drug discovery, which the chip designer can then potentially license out, the companies said on Wednesday.Recursion will train AI models on Nvidia's cloud platform using its own biological and chemical datasets exceeding 23,000 terabytes.Nvidia could then license the AI models to biotech firms via BioNeMo, a generative AI cloud service for drug discovery that it rolled out widely earlier this year.The companies did not specify whether Nvidia will take a stake in Recursion. The drug developer did not immediately respond to a Reuters request for clarification.Recursion, which has partnered with drugmakers such as Bayer and Roche, plans to use Nvidia's software to support its own pipeline as well as current and future partners.The biopharma company, which went public in 2021, runs the Recursion OS platform that gives drugmakers access to datasets required for designing and developing therapeutics.Recursion is conducting human trials for five of its drugs, including a candidate that is in mid-stage trials to treat a type of neurovascular disease caused by malformation of small blood vessels in the brain. The company uses AI to discover drugs.Recursion's other backers include Abu Dhabi sovereign investor Mubadala and UK-based investment firm Baillie Gifford & Co.In May, Recursion, whose advisers include AI pioneer Yoshua Bengio, had agreed to buy two companies in the AI-driven drug discovery space for $87.5 million. Recursion Pharmaceuticals, Inc. surged over 107% while NVIDIA Corp gained nearly 2% in premarket trading.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":106475472,"gmtCreate":1689262458541,"gmtModify":1689262965130,"authorId":4149410557710562,"author":{"id":4149410557710562,"authorId":4149410557710562,"name":"Mohamed elsage","avatar":"https://community-static.tradeup.com/news/a43cd2065e9d566c3da3119bc912aa93","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":197325953466504,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">100000000000000</span>","text":"<span class=\"s1\">100000000000000</span>","html":"<span class=\"s1\">100000000000000</span>"},{"id":106475470,"gmtCreate":1689262403949,"gmtModify":1689262965088,"authorId":4149410557710562,"author":{"id":4149410557710562,"authorId":4149410557710562,"name":"Mohamed elsage","avatar":"https://community-static.tradeup.com/news/a43cd2065e9d566c3da3119bc912aa93","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":197325953466504,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">5000000000000</span>","text":"<span class=\"s1\">5000000000000</span>","html":"<span class=\"s1\">5000000000000</span>"},{"id":106475468,"gmtCreate":1689262372189,"gmtModify":1689262965042,"authorId":4149410557710562,"author":{"id":4149410557710562,"authorId":4149410557710562,"name":"Mohamed elsage","avatar":"https://community-static.tradeup.com/news/a43cd2065e9d566c3da3119bc912aa93","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":197325953466504,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">5000000000</span>","text":"<span class=\"s1\">5000000000</span>","html":"<span class=\"s1\">5000000000</span>"}],"langContent":"EN"},{"id":197176727261336,"gmtCreate":1689179009209,"gmtModify":1689179332862,"author":{"id":"4119963323587952","authorId":"4119963323587952","name":"Kennoobie","avatar":"https://community-static.tradeup.com/news/13ad37a0e06c2dfd42ac4f2b5a70b190","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":1,"crmLevelSwitch":1},"htmlText":"Boom ... shooting up crazily","listText":"Boom ... shooting up crazily","text":"Boom ... shooting up crazily","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/197176727261336","repostId":2350044430,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":106475581,"gmtCreate":1689275813256,"gmtModify":1689275819584,"authorId":4149410557710562,"author":{"id":4149410557710562,"authorId":4149410557710562,"name":"Mohamed elsage","avatar":"https://community-static.tradeup.com/news/a43cd2065e9d566c3da3119bc912aa93","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":197176727261336,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">1000000000</span>","text":"<span class=\"s1\">1000000000</span>","html":"<span class=\"s1\">1000000000</span>"}],"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":18,"commentSize":0,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2350044430"}